Applied Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLT and other ETFs, options, and stocks.About APLT
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications.
CEOLeslie David Funtleyder
CEOLeslie David Funtleyder
Employees35
Employees35
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2016
Founded2016
Employees35
Employees35
APLT Key Statistics
Market cap16.38M
Market cap16.38M
Price-Earnings ratio-1.14
Price-Earnings ratio-1.14
Dividend yield—
Dividend yield—
Average volume13.53M
Average volume13.53M
High today$0.1179
High today$0.1179
Low today$0.108
Low today$0.108
Open price$0.1098
Open price$0.1098
Volume6.73M
Volume6.73M
52 Week high$1.50
52 Week high$1.50
52 Week low$0.10
52 Week low$0.10
Stock Snapshot
Applied Therapeutics(APLT) stock is priced at $0.11, giving the company a market capitalization of 16.38M. It carries a P/E multiple of -1.14.
As of 2025-12-27, Applied Therapeutics(APLT) stock has fluctuated between $0.11 and $0.12. The current price stands at $0.11, placing the stock +0.8% above today's low and -7.6% off the high.
Applied Therapeutics(APLT) shares are trading with a volume of 6.73M, against a daily average of 13.53M.
During the past year, Applied Therapeutics(APLT) stock moved between $0.10 at its lowest and $1.50 at its peak.
During the past year, Applied Therapeutics(APLT) stock moved between $0.10 at its lowest and $1.50 at its peak.
People also own
Based on the portfolios of people who own APLT. This list is generated using Robinhood data, and it’s not a recommendation.